e-learning
resources
London 2016
Monday, 05.09.2016
Epidemiological insights into tuberculosis pathogenesis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Preventive treatment for latent tuberculosis infection
Filiz Duyar Ağca (Ankara, Turkey), Filiz Duyar Agca, Onur Aksu Ceyhan
Source:
International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Session:
Epidemiological insights into tuberculosis pathogenesis
Session type:
Thematic Poster
Number:
2744
Disease area:
Paediatric lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Filiz Duyar Ağca (Ankara, Turkey), Filiz Duyar Agca, Onur Aksu Ceyhan. Preventive treatment for latent tuberculosis infection. Eur Respir J 2016; 48: Suppl. 60, 2744
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
A novel nurse-led approach improves treatment completion rates for latent tuberculosis infection (LTBI) treatment
Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches
Year: 2014
Liver injury in treatment of latent tuberculosis infection - is the age cut-off for treatment justified?
Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches
Year: 2014
Latent TB infection: Patient choices and completion of treatment
Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics
Year: 2016
Do we need to screen for latent TB when initiating a methotrexate treatment?
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013
The effectiveness of programmatic management of latent tuberculosis infection in the Netherlands
Source: International Congress 2015 – Latent TB infection and screening
Year: 2015
Social determinants of drug-susceptible and drug resistant tuberculosis
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016
Delay in pulmonary tuberculosis treatment in Croatia
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013
Is there a need for prolonged follow up in mono-drug resistant TB?
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014
Prevalence of latent tuberculosis infection among household contacts and community controls in South India
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013
High prevalence of hepatitis C among patients with drug-resistant tuberculosis and its impact on the treatment outcome in Azerbaijan prisons
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Characteristics of tuberculosis (TB) in patients that died from TB in Poland
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016
Impact and management of TB childhood outbreaks in EU/EEA
Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis
Year: 2013
Public health guidance on programmatic management of latent tuberculosis infection in the European Union/European Economic Area
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection I
Year: 2019
The causes of death among patients with tuberculosis
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015
The incidence of MDR-TB in new and retreatment cases of HIV and pulmonary tuberculosis co-infection
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013
Monitoring latent tuberculosis infection diagnosis and management in the Netherlands
Source: Eur Respir J 2016; 47:1492-1501
Year: 2016
Prevention of TB in areas of high incidence
Source: Eur Respir Mon 2012; 58: 84-94
Year: 2012
Recurrent TB in Ireland is predominantly due to relapsed infection and is frequently associated with poor compliance with therapy
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016
Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016
Factors associated with pulmonary tuberculosis treatment outcome in Kocaeli; Turkey
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept